Objective: To investigate the possibility of drug-free remission in patients with psoriatic arthritis (PsA) in continuous remission.
Methods: Prospective observational study in disease-modifying antirheumatic drug (DMARD)-treated PsA patients in continuous disease remission (no musculoskeletal symptoms, no or minimal skin/nail disease) for at least 6 months. Demographic, disease-specific and ultrasound parameters were assessed at baseline.